Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Egeruan Babatunde Imoukhuede"'
Autor:
Alfred B Tiono, Issa Nébié, Nicholas Anagnostou, Aboubacar S Coulibaly, Georgina Bowyer, Erika Lam, Edith C Bougouma, Alphonse Ouedraogo, Jean Baptist B Yaro, Aïssata Barry, Rachel Roberts, Tommy Rampling, Carly Bliss, Susanne Hodgson, Alison Lawrie, Amidou Ouedraogo, Egeruan Babatunde Imoukhuede, Katie J Ewer, Nicola K Viebig, Amidou Diarra, Odile Leroy, Philip Bejon, Adrian V S Hill, Sodiomon B Sirima
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208328 (2018)
BackgroundHeterologous prime boost immunization with chimpanzee adenovirus 63 (ChAd63) and Modified Vaccinia Virus Ankara (MVA) vectored vaccines is a strategy previously shown to provide substantial protective efficacy against P. falciparum infectio
Externí odkaz:
https://doaj.org/article/9f0b268f48ec4628a56b67c82fad2f57
Autor:
Vibian Angwenyi, Kwaku-Poku Asante, Abdoulaye Traoré, Lawrence Gyabaa Febir, Charlotte Tawiah, Anthony Kwarteng, Alphonse Ouédraogo, Sodiomon Bienvenue Sirima, Seth Owusu-Agyei, Egeruan Babatunde Imoukhuede, Jayne Webster, Daniel Chandramohan, Sassy Molyneux, Caroline Jones
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124554 (2015)
Clinical trials conducted in Africa often require substantial investments to support trial centres and public health facilities. Trial resources could potentially generate benefits for routine health service delivery but may have unintended consequen
Externí odkaz:
https://doaj.org/article/f13062bbf8e74e74a8b2d7da9df5cf45
Autor:
Sabine Bélard, Saadou Issifou, Aurore B Hounkpatin, Frieder Schaumburg, Ulysse Ateba Ngoa, Meral Esen, Rolf Fendel, Pablo Martinez de Salazar, Raymund E Mürbeth, Paul Milligan, Nathalie Imbault, Egeruan Babatunde Imoukhuede, Michael Theisen, Søren Jepsen, Ramadhani A Noor, Brenda Okech, Peter G Kremsner, Benjamin Mordmüller
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e22525 (2011)
GMZ2 is a fusion protein of Plasmodium falciparum merozoite surface protein 3 (MSP3) and glutamate rich protein (GLURP) that mediates an immune response against the blood stage of the parasite. Two previous phase I clinical trials, one in naïve Euro
Externí odkaz:
https://doaj.org/article/76cb18f105124753b1e363052ff919d0
Publikováno v:
Human vaccines. 6(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::679723c688e474508ccb6a2fd0161c77
https://pubmed.ncbi.nlm.nih.gov/20671434
https://pubmed.ncbi.nlm.nih.gov/20671434